Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Vitamin D deficiency is a global health concern, with its prevalence reaching alarming rates among patients with chronic kidney disease (CKD), particularly those requiring dialysis. It ranges from 50-98% among hemodialysis patients and even higher at 86-100% for those on peritoneal dialysis. It is considered a mortality risk factor, however, the pathophysiology is still unclear. This study aimed to determine the local prevalence and factors associated with Vitamin D deficiency among dialysis patients.
A cross-sectional study was conducted wherein all end-stage renal disease (ESRD) patients aged >19years old and on maintenance dialysis >3months were included. The mean Vitamin D, intact parathyroid hormone, ionized calcium, phosphorus, alkaline phosphatase and hematocrit were recorded. Correlation of age, gender, pre-dialysis co-morbidities, dialysis vintage and frequency were determined using spearman rank correlation coefficient, chi-square test and regression analysis with odds ratio.
A total of 240 chronic dialysis patients in our unit were identified. Out of the 240 patients, 168 patients were included. The patients were distributed into Vitamin D sufficient and insufficient/deficient group. The prevalence rate of Vitamin D insufficiency and deficiency is low at 11.9% and 6%, respectively. Low hematocrit (p=0.032) and high alkaline phosphatase levels (p=0.022) were considered statistically significant among Vitamin D insufficient/deficient group. Thrice a week dialysis is positively correlated with Vitamin D levels (r= 27.995, p=<0.01, 95% CI -0.245, 1.705). Patients, either on hemodialysis or peritoneal dialysis, have significantly increased Vitamin D levels by 104.64 ng/mL (p=0.0016).
The low prevalence of Vitamin D insufficiency/deficiency establishes the evidence that this disease condition is not universally observed among dialysis-requiring patients. Patients, either on hemodialysis or peritoneal dialysis, shows a significant increase in Vitamin D levels by 104.64ng/mL (p=0.0016). Thrice a week dialysis is positively correlated with Vitamin D levels (r= 27.995, p=<0.01, 95% CI -0.245, 1.705). Medication use among these patients affects their serum Vitamin D levels.
